SlideShare a Scribd company logo
1 of 22
Download to read offline
Older Adult Survivorship
Meghan Routt, MSN ANP/GNP-BC, AOCNP
• I have no financial conflict of interest
Objectives
• At the end of this session the participant will be able to:
• Describe some of the main barriers to treatment in the older adult population
• Identify common side effects of cancer treatment and specific challenges of
treatment in the older adult
• Identify four common geriatric syndromes
The “Silver Tsunami”
• By the year 2050, the number of adults over the age of 65 will double
(to approximately 89 million people) and will contribute a 45%
increase in the number of people developing cancer 1
• Adults over the age of 65 account for 54% of all cancer patients and
69.5% of all cancer deaths occur in this age group2
• Aging is the biggest risk factor for developing cancer
Why do we care?
• Older adults have certain changes in their physiology which providers
need to keep in mind when prescribing medications or other therapy
Body system Changes in the older adult
Skin Loses elasticity, loses ability to keep moisture in,
thins, more apt for injury
Renal function Decreases with age, lose 1ml/min/year of GFR
after the age of 30. Renal blood flow decreases
by 50%
Urinary Incontinence is NEVER normal, increased
frequency of urinary tract infections due to
impaired bladder emptying
Gastrointestinal Constipation: due to medication, due to
inactivity, due to decreased peristalsis
Diarrhea: more prone to dehydration, increased
risk for falls
Why do we care?
Body system Changes in the older adult
Liver Decreased ability to absorb and metabolize
medications, medication interaction
Cardiovascular Average systolic BP increases, Stroke volume
does not change in older adult, increased
incidence of peripheral vascular disease
Pulmonary Decreased elasticity of lungs, increase in airway
reactivity, decreased cough reflex
Immune system Immunity decreases with age, T cell function
decreases, B cells do not bind as tightly to
antibodies, increase in auto-antibodies
It is important to note older adults do not present with the same signs and
symptoms as their younger counterparts, in fact they may present atypically
with even severe illness3
Guidelines to treat older adults with cancer
NCCN Clinical Practice Guidelines
• It is important to note, treatment is based on the patient’s goals and
age is not considered a primary risk factor for surgical or medical
treatment3
• Unfortunately, studies have shown older adults do not receive
“standard of care” treatment for many diseases including breast
cancer, colon cancer, kidney, bladder
• Comprehensive Geriatric Assessments (CGA) should be done prior to
any treatment
• Includes assessments in all domains of health
• Nutrition, Activities of daily living, Depression, Dementia, Health
related quality of life, Physical exertion
NCCN Clinical Practice Guidelines
• Mucositis
• Early hospitalization is needed for patients who develop dysphagia/diarrhea
• Provide nutritional support
• Bone marrow suppression
• Prophylactic colony-stimulating factors are needed when dose intensity is required for
response
• Neurotoxicity
• Monitor hearing loss, peripheral neuropathy and cognitive dysfunction
• Cardiac toxicity
• Monitor for symptomatic or asymptomatic heart failure, especially with the use of
anthracyclines and trastuzumab
• Renal toxicity
• Adjust dose for glomerular filtration rate to reduce systemic toxicity
• Insomnia
• Nonpharmacologic methods are recommended
• Do not use hypnotics, Benadryl or benzodiazepenes as first line treatment for insomnia
Surgery and the older adult
Chemotherapy and the Older Adult
• Two specific tools for the older adult in monitoring chemotherapy risk
assessment and toxicity:
• Chemotherapy Risk Assessment Scale for High-Age Patients
(CRASH) Score: http://eforms.moffitt.org/crashScore.aspx
• Cancer and Aging Research Group (CARG) Chemo toxicity
Calculator http://www.mycarg.org
A cancer
survivor story…
Tom’s story
• Diagnosed with metastatic prostate cancer to bone (right hip and
sacrum)
• Previously underwent a total prostatectomy
• Now receiving Lupron q6 months and Xjeva monthly
• Tom’s major issues:
• Transportation/Family Dynamics
• Pain
Tom’s Survivorship issues
• Transportation and family dynamics
• His ex-wife Dottie was his primary means of transportation as well
as picked up him controlled substances as he no longer drives
• Dottie is not his healthcare power of attorney
• Dottie has had issues with alcoholism
• Dottie recently diagnosed with a brain tumor
• Pain
• Treating urologist did not assess Tom’s pain
• His primary care provider has him on MS Contin 30mg BID with norco
for breakthrough
Older adult pain management
• Pain is one of the most frequently reported symptom in this age
group regardless of survivorship stage5
• Furthermore, at least 42% of older adult patients with cancer report
unrelieved pain6
• This is due to many factors but primarily:
• Older adults’ believe that pain is a normal part of aging
• They do not want to become “addicted”
• Clinicians do not adequately assess their pain (occurs a lot in
patients who have cognitive impairment)
Older Adult Cancer Pain Management
• Unrelieved pain can lead to depression, sleep, appetite disturbances
and an increase in healthcare utilization and cost7
• Pain is often nociceptive and neuropathic pain
• Older adults may achieve pain relief at lower doses than younger
people who report the same severity8
• Acetaminophen or other non-steroidal anti-inflammatories is first
line treatment for nociceptive pain
• Narcotics often provide good pain relief and methadone is a good
long acting agent in older adults due to minimal renal clearance.
Older adult cancer pain management
Retrieved from: http://www.who.int/cancer/palliative/painladder/en/
Other Geriatric Survivorship Issues
• Polypharmacy
• Defined as the use of 9 or more medications
• It is estimated that all people age 65 and above take two to nine
prescriptions each day
• Additionally, 50% take two to four over the counter medications
daily and 47-59% ingest vitamins or minerals daily9
• Biggest issue occurs when a medication is prescribed to counteract
a side effect of another medication
• Significant risk factor in the exacerbation of common geriatric
syndromes such as dementia, delirium, depression, malnutrition,
falls or urinary incontinence9
Wait…what are geriatric syndromes?
• The term geriatric syndromes incorporate unique features of common
health conditions in older adults
• Include: Dementia, Failure to thrive, delirium, Falls, urinary
incontinence
• People can have one, some, or none of these]
Risk for Falls
• Thirty percent of older adults who live at home experience at least
one fall annually11
• Injurious falls are also the primary cause of accidental deaths in this
age group11
• It is imperative older adult cancer survivors be asked about whether
they have fallen or not as well as be screened at every appointment1
Questions?
References
• 1. US Department of Commerce Census Bureau (2012). Population projections. Retrieved February 15, 2016 from
http://www.census.gov/population/projections/data/national/2012/summarytables.html.
• 2. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF…& Cronin KA (eds). (2013). SEER Cancer Statistics Review, 1975-2011, National Cancer
Institute. Bethesda, MD retrieved February 15, 2016 from: http://seer.cancer.gov/csr/1975_2011/ .
• 3. Walker, M., Spivak, M., & Sebastian, M. (2014). The impact of aging physiology in critical care. Critical Care Nursing Clinics of North America, 26, 7-14.
• 4. National Comprehensive Cancer Network. (2016). NCCN guidelines: Older Adult Oncology. Version 1. 2016. Retrieved from:
https://www.nccn.org/professionals/physician_gls/pdf/senior.pdf
• 5. Mohanty, S., Rosethal, B.A., Russell, M.M., Neuman, M.D, Ko, B.Y & Esanola, N.F. (2012) Optimal perioperative management of the geriatric patient: Best
practices guideline from ACS NSQIP/American Geriatrics Society. Retrieved from:
https://www.facs.org/~/media/files/quality%20programs/geriatric/acs%20nsqip%20geriatric%202016%20guidelines.ashx
• 6. Beck, S., Towsley, G., Caserta, M., Lindau, K. & Dudley, W. (2009). Symptom experiences and quality of life of rural and urban older adult cancer survivors. Cancer
Nursing, 32, 359-369.
• 7. Barford, K. & D’Olimpio, J.T. (2008). Symptom management in geriatric oncology: Practical treatment considerations and current challenges. Current Treatment
Options in Oncology, 9, 204-214.
• 8. Sutton, L.M., Denmark-Wahnefried, W., & Clipp, E.C. (2003). Management of terminal cancer in elderly patients, Lancet Oncology, 4, 149-157.
• 9. Mercadante, S. & Arcuri, E. (2007). Pharmacological management of cancer pain in the elderly. Drugs and Aging, 24, 761-776
• 10. Flood, K.L., Carrol, M.B., Le, C.V. & Brown, C.J. (2009). Polypharmacy in hospitalized older adult cancer patients: Experience from a prospective, observational
study of an oncology-acute care for elders unit. American Journal of Geriatric Pharmacotherapy, 7, 151-158.
• 11. Day., L., Fildes, B., Gordon, I., Fitzharris, M., Flamer, H., & Lord, S. (2002). Randomised factorial trial of falls prevention among older people living in their own
homes. BMJ, 325, 128.

More Related Content

What's hot

What Men Told Us: Prostate Cancer Survey Results, Oct. 1, 2020
What Men Told Us: Prostate Cancer Survey Results, Oct. 1, 2020What Men Told Us: Prostate Cancer Survey Results, Oct. 1, 2020
What Men Told Us: Prostate Cancer Survey Results, Oct. 1, 2020Canadian Cancer Survivor Network
 
4th Annual Early Age Onset Colorectal Cancer Summit: Transforming Family Heal...
4th Annual Early Age Onset Colorectal Cancer Summit: Transforming Family Heal...4th Annual Early Age Onset Colorectal Cancer Summit: Transforming Family Heal...
4th Annual Early Age Onset Colorectal Cancer Summit: Transforming Family Heal...Colon Cancer Challenge Foundation
 
Oct 2015 Webinar: Dr. Lieu, Precision Medicine
Oct 2015 Webinar: Dr. Lieu, Precision MedicineOct 2015 Webinar: Dr. Lieu, Precision Medicine
Oct 2015 Webinar: Dr. Lieu, Precision MedicineFight Colorectal Cancer
 
Communities of Color and Participation in Breast Cancer Research
Communities of Color and Participation in Breast Cancer ResearchCommunities of Color and Participation in Breast Cancer Research
Communities of Color and Participation in Breast Cancer Researchbkling
 
Strategies for Long-term Management of Recurrent Ovarian Cancer
Strategies for Long-term Management of Recurrent Ovarian CancerStrategies for Long-term Management of Recurrent Ovarian Cancer
Strategies for Long-term Management of Recurrent Ovarian Cancerbkling
 
5th Annual Early Age Onset Colorectal Cancer - Session V: Part II
5th Annual Early Age Onset Colorectal Cancer - Session V: Part II5th Annual Early Age Onset Colorectal Cancer - Session V: Part II
5th Annual Early Age Onset Colorectal Cancer - Session V: Part IIColon Cancer Challenge Foundation
 
Meeting the Cancer Survivorship Needs of Colorectal Cancer: The Wellness Beyo...
Meeting the Cancer Survivorship Needs of Colorectal Cancer: The Wellness Beyo...Meeting the Cancer Survivorship Needs of Colorectal Cancer: The Wellness Beyo...
Meeting the Cancer Survivorship Needs of Colorectal Cancer: The Wellness Beyo...Health Sciences North | Horizon Santé Nord
 
Ovarian Cancer: What's New?
Ovarian Cancer: What's New?Ovarian Cancer: What's New?
Ovarian Cancer: What's New?bkling
 
Communicating hope and truth: A presentation for health care professionals
Communicating hope and truth: A presentation for health care professionalsCommunicating hope and truth: A presentation for health care professionals
Communicating hope and truth: A presentation for health care professionalsbkling
 
5th Annual Early Age Onset Colorectal Cancer Summit - Session III
5th Annual Early Age Onset Colorectal Cancer Summit - Session III5th Annual Early Age Onset Colorectal Cancer Summit - Session III
5th Annual Early Age Onset Colorectal Cancer Summit - Session IIIColon Cancer Challenge Foundation
 
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!National Ovarian Cancer Coalition
 
Clinical Trials for Ovarian Cancer: Fact vs. Fiction
Clinical Trials for Ovarian Cancer: Fact vs. FictionClinical Trials for Ovarian Cancer: Fact vs. Fiction
Clinical Trials for Ovarian Cancer: Fact vs. Fictionbkling
 

What's hot (20)

Discover Personalized Medicine: Setsuko Chambers, MD
Discover Personalized Medicine: Setsuko Chambers, MD Discover Personalized Medicine: Setsuko Chambers, MD
Discover Personalized Medicine: Setsuko Chambers, MD
 
What Men Told Us: Prostate Cancer Survey Results, Oct. 1, 2020
What Men Told Us: Prostate Cancer Survey Results, Oct. 1, 2020What Men Told Us: Prostate Cancer Survey Results, Oct. 1, 2020
What Men Told Us: Prostate Cancer Survey Results, Oct. 1, 2020
 
Ovarian Cancer: Three sides of the Story: Yuko Abbott, LCSW
Ovarian Cancer: Three sides of the Story: Yuko Abbott, LCSW  Ovarian Cancer: Three sides of the Story: Yuko Abbott, LCSW
Ovarian Cancer: Three sides of the Story: Yuko Abbott, LCSW
 
4th Annual Early Age Onset Colorectal Cancer Summit: Transforming Family Heal...
4th Annual Early Age Onset Colorectal Cancer Summit: Transforming Family Heal...4th Annual Early Age Onset Colorectal Cancer Summit: Transforming Family Heal...
4th Annual Early Age Onset Colorectal Cancer Summit: Transforming Family Heal...
 
Oct 2015 Webinar: Dr. Lieu, Precision Medicine
Oct 2015 Webinar: Dr. Lieu, Precision MedicineOct 2015 Webinar: Dr. Lieu, Precision Medicine
Oct 2015 Webinar: Dr. Lieu, Precision Medicine
 
Goals of Care: Changing the Game for Lung Cancer Patients
Goals of Care: Changing the Game for Lung Cancer PatientsGoals of Care: Changing the Game for Lung Cancer Patients
Goals of Care: Changing the Game for Lung Cancer Patients
 
5th Annual Early Age Onset Colorectal Cancer - Session I
5th Annual Early Age Onset Colorectal Cancer - Session I5th Annual Early Age Onset Colorectal Cancer - Session I
5th Annual Early Age Onset Colorectal Cancer - Session I
 
Communities of Color and Participation in Breast Cancer Research
Communities of Color and Participation in Breast Cancer ResearchCommunities of Color and Participation in Breast Cancer Research
Communities of Color and Participation in Breast Cancer Research
 
Strategies for Long-term Management of Recurrent Ovarian Cancer
Strategies for Long-term Management of Recurrent Ovarian CancerStrategies for Long-term Management of Recurrent Ovarian Cancer
Strategies for Long-term Management of Recurrent Ovarian Cancer
 
5th Annual Early Age Onset Colorectal Cancer - Session V: Part II
5th Annual Early Age Onset Colorectal Cancer - Session V: Part II5th Annual Early Age Onset Colorectal Cancer - Session V: Part II
5th Annual Early Age Onset Colorectal Cancer - Session V: Part II
 
Meeting the Cancer Survivorship Needs of Colorectal Cancer: The Wellness Beyo...
Meeting the Cancer Survivorship Needs of Colorectal Cancer: The Wellness Beyo...Meeting the Cancer Survivorship Needs of Colorectal Cancer: The Wellness Beyo...
Meeting the Cancer Survivorship Needs of Colorectal Cancer: The Wellness Beyo...
 
Ovarian Cancer: What's New?
Ovarian Cancer: What's New?Ovarian Cancer: What's New?
Ovarian Cancer: What's New?
 
Communicating hope and truth: A presentation for health care professionals
Communicating hope and truth: A presentation for health care professionalsCommunicating hope and truth: A presentation for health care professionals
Communicating hope and truth: A presentation for health care professionals
 
feasibility study
feasibility studyfeasibility study
feasibility study
 
5th Annual Early Age Onset Colorectal Cancer Summit - Session III
5th Annual Early Age Onset Colorectal Cancer Summit - Session III5th Annual Early Age Onset Colorectal Cancer Summit - Session III
5th Annual Early Age Onset Colorectal Cancer Summit - Session III
 
NCCN Guidelines for Patients: Ovarian Cancer
NCCN Guidelines for Patients: Ovarian CancerNCCN Guidelines for Patients: Ovarian Cancer
NCCN Guidelines for Patients: Ovarian Cancer
 
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
 
Clinical Trials for Ovarian Cancer: Fact vs. Fiction
Clinical Trials for Ovarian Cancer: Fact vs. FictionClinical Trials for Ovarian Cancer: Fact vs. Fiction
Clinical Trials for Ovarian Cancer: Fact vs. Fiction
 
Fifth Annual Metastatic Breast Cancer Forum
Fifth Annual Metastatic Breast Cancer ForumFifth Annual Metastatic Breast Cancer Forum
Fifth Annual Metastatic Breast Cancer Forum
 
WEBINAR: Breast Screening and Breast Density
WEBINAR: Breast Screening and Breast DensityWEBINAR: Breast Screening and Breast Density
WEBINAR: Breast Screening and Breast Density
 

Viewers also liked

Genetic Syndromes and Thyroid Cancer by Pamela Brock, MS, LGC
Genetic Syndromes and Thyroid Cancer by Pamela Brock, MS, LGCGenetic Syndromes and Thyroid Cancer by Pamela Brock, MS, LGC
Genetic Syndromes and Thyroid Cancer by Pamela Brock, MS, LGCOSUCCC - James
 
Ohio State's ASH Review 2017 - Update in Myeloma
Ohio State's ASH Review 2017 - Update in MyelomaOhio State's ASH Review 2017 - Update in Myeloma
Ohio State's ASH Review 2017 - Update in MyelomaOSUCCC - James
 
ASCO 2016 Thoracic Review
ASCO 2016 Thoracic ReviewASCO 2016 Thoracic Review
ASCO 2016 Thoracic ReviewOSUCCC - James
 
RATIONAL COMBINATION IMMUNOTHERAPY: The best of ASCO16 clinical data
RATIONAL COMBINATION IMMUNOTHERAPY: The best of ASCO16 clinical dataRATIONAL COMBINATION IMMUNOTHERAPY: The best of ASCO16 clinical data
RATIONAL COMBINATION IMMUNOTHERAPY: The best of ASCO16 clinical dataPaul D. Rennert
 
Genetic predisposition to papillary thyroid cancer by Albert de la Chapelle, ...
Genetic predisposition to papillary thyroid cancer by Albert de la Chapelle, ...Genetic predisposition to papillary thyroid cancer by Albert de la Chapelle, ...
Genetic predisposition to papillary thyroid cancer by Albert de la Chapelle, ...OSUCCC - James
 
Survivorship Issues Genetics 2016
Survivorship Issues Genetics 2016Survivorship Issues Genetics 2016
Survivorship Issues Genetics 2016OSUCCC - James
 
Ohio State's ASH Review 2017 - Blood and Marrow Transplantation
Ohio State's ASH Review 2017 - Blood and Marrow TransplantationOhio State's ASH Review 2017 - Blood and Marrow Transplantation
Ohio State's ASH Review 2017 - Blood and Marrow TransplantationOSUCCC - James
 
ASCO 2016 Review Neuro-oncology
ASCO 2016 Review Neuro-oncologyASCO 2016 Review Neuro-oncology
ASCO 2016 Review Neuro-oncologyOSUCCC - James
 
Ohio State's ASH Review 2017 - Myeloproliferative Disorders
Ohio State's ASH Review 2017 - Myeloproliferative DisordersOhio State's ASH Review 2017 - Myeloproliferative Disorders
Ohio State's ASH Review 2017 - Myeloproliferative DisordersOSUCCC - James
 
abc oncology . Colon session
abc oncology . Colon sessionabc oncology . Colon session
abc oncology . Colon sessionFadi Farhat
 
ASCO 2016 Sarcoma Review
ASCO 2016 Sarcoma ReviewASCO 2016 Sarcoma Review
ASCO 2016 Sarcoma ReviewOSUCCC - James
 
How to Approach Systemic Treatment for Metastatic Disease
How to Approach Systemic Treatment for Metastatic DiseaseHow to Approach Systemic Treatment for Metastatic Disease
How to Approach Systemic Treatment for Metastatic DiseaseMelanoma Research Foundation
 
ASCO Review Benign Hematology
ASCO Review Benign HematologyASCO Review Benign Hematology
ASCO Review Benign HematologyOSUCCC - James
 
Ohio State's ASH Review 2017 - Benign Hematology
Ohio State's ASH Review 2017 - Benign HematologyOhio State's ASH Review 2017 - Benign Hematology
Ohio State's ASH Review 2017 - Benign HematologyOSUCCC - James
 
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...OSUCCC - James
 
Oncology Immunotherapy - Nivolumab and other PD-1/PD-L1 Targeted Agents (061213)
Oncology Immunotherapy - Nivolumab and other PD-1/PD-L1 Targeted Agents (061213)Oncology Immunotherapy - Nivolumab and other PD-1/PD-L1 Targeted Agents (061213)
Oncology Immunotherapy - Nivolumab and other PD-1/PD-L1 Targeted Agents (061213)Will Roettger
 

Viewers also liked (20)

Genetic Syndromes and Thyroid Cancer by Pamela Brock, MS, LGC
Genetic Syndromes and Thyroid Cancer by Pamela Brock, MS, LGCGenetic Syndromes and Thyroid Cancer by Pamela Brock, MS, LGC
Genetic Syndromes and Thyroid Cancer by Pamela Brock, MS, LGC
 
Ohio State's ASH Review 2017 - Update in Myeloma
Ohio State's ASH Review 2017 - Update in MyelomaOhio State's ASH Review 2017 - Update in Myeloma
Ohio State's ASH Review 2017 - Update in Myeloma
 
ASCO 2016 Thoracic Review
ASCO 2016 Thoracic ReviewASCO 2016 Thoracic Review
ASCO 2016 Thoracic Review
 
RATIONAL COMBINATION IMMUNOTHERAPY: The best of ASCO16 clinical data
RATIONAL COMBINATION IMMUNOTHERAPY: The best of ASCO16 clinical dataRATIONAL COMBINATION IMMUNOTHERAPY: The best of ASCO16 clinical data
RATIONAL COMBINATION IMMUNOTHERAPY: The best of ASCO16 clinical data
 
Genetic predisposition to papillary thyroid cancer by Albert de la Chapelle, ...
Genetic predisposition to papillary thyroid cancer by Albert de la Chapelle, ...Genetic predisposition to papillary thyroid cancer by Albert de la Chapelle, ...
Genetic predisposition to papillary thyroid cancer by Albert de la Chapelle, ...
 
Survivorship Issues Genetics 2016
Survivorship Issues Genetics 2016Survivorship Issues Genetics 2016
Survivorship Issues Genetics 2016
 
Ohio State's ASH Review 2017 - Blood and Marrow Transplantation
Ohio State's ASH Review 2017 - Blood and Marrow TransplantationOhio State's ASH Review 2017 - Blood and Marrow Transplantation
Ohio State's ASH Review 2017 - Blood and Marrow Transplantation
 
ASCO 2016 Review Neuro-oncology
ASCO 2016 Review Neuro-oncologyASCO 2016 Review Neuro-oncology
ASCO 2016 Review Neuro-oncology
 
Ohio State's ASH Review 2017 - Myeloproliferative Disorders
Ohio State's ASH Review 2017 - Myeloproliferative DisordersOhio State's ASH Review 2017 - Myeloproliferative Disorders
Ohio State's ASH Review 2017 - Myeloproliferative Disorders
 
abc oncology . Colon session
abc oncology . Colon sessionabc oncology . Colon session
abc oncology . Colon session
 
ASCO 2016 Sarcoma Review
ASCO 2016 Sarcoma ReviewASCO 2016 Sarcoma Review
ASCO 2016 Sarcoma Review
 
Asco 2016 GU Review
Asco 2016 GU ReviewAsco 2016 GU Review
Asco 2016 GU Review
 
How to Approach Systemic Treatment for Metastatic Disease
How to Approach Systemic Treatment for Metastatic DiseaseHow to Approach Systemic Treatment for Metastatic Disease
How to Approach Systemic Treatment for Metastatic Disease
 
ASCO Review Benign Hematology
ASCO Review Benign HematologyASCO Review Benign Hematology
ASCO Review Benign Hematology
 
Ohio State's ASH Review 2017 - Benign Hematology
Ohio State's ASH Review 2017 - Benign HematologyOhio State's ASH Review 2017 - Benign Hematology
Ohio State's ASH Review 2017 - Benign Hematology
 
Gastric cancer
Gastric cancerGastric cancer
Gastric cancer
 
DCF vs ECF in gastric cancer
DCF vs  ECF  in gastric cancerDCF vs  ECF  in gastric cancer
DCF vs ECF in gastric cancer
 
Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer C...
Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer C...Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer C...
Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer C...
 
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...
 
Oncology Immunotherapy - Nivolumab and other PD-1/PD-L1 Targeted Agents (061213)
Oncology Immunotherapy - Nivolumab and other PD-1/PD-L1 Targeted Agents (061213)Oncology Immunotherapy - Nivolumab and other PD-1/PD-L1 Targeted Agents (061213)
Oncology Immunotherapy - Nivolumab and other PD-1/PD-L1 Targeted Agents (061213)
 

Similar to Older Adult Cancer Survivorship Challenges

Cancer• What is cancer• Cancer statistics• Risk Fac.docx
Cancer• What is cancer• Cancer statistics• Risk Fac.docxCancer• What is cancer• Cancer statistics• Risk Fac.docx
Cancer• What is cancer• Cancer statistics• Risk Fac.docxbartholomeocoombs
 
Survivorship and quaility of life
Survivorship and quaility of lifeSurvivorship and quaility of life
Survivorship and quaility of lifeEuropa Uomo EPAD
 
Screening and Preventive Care in OBGN .pdf
Screening and Preventive Care in OBGN .pdfScreening and Preventive Care in OBGN .pdf
Screening and Preventive Care in OBGN .pdfElhadi Miskeen
 
2023 End of life care.pptx
2023 End of life care.pptx2023 End of life care.pptx
2023 End of life care.pptxWorkuDaba
 
2023 End of life care.pptx
2023 End of life care.pptx2023 End of life care.pptx
2023 End of life care.pptxWorkuDaba
 
2023 End of life care.pptx
2023 End of life care.pptx2023 End of life care.pptx
2023 End of life care.pptxGeletoHinika
 
Brian Sick, M.D.
Brian Sick, M.D.Brian Sick, M.D.
Brian Sick, M.D.smsherman
 
Geriatric Syndromes [Autosaved].pptx
Geriatric Syndromes [Autosaved].pptxGeriatric Syndromes [Autosaved].pptx
Geriatric Syndromes [Autosaved].pptxJunaid Khan
 
Lines of ttt of p ca
Lines of ttt of p caLines of ttt of p ca
Lines of ttt of p caAhmed Eliwa
 
NPEK_Cancer Presentation.pptx
NPEK_Cancer Presentation.pptxNPEK_Cancer Presentation.pptx
NPEK_Cancer Presentation.pptxChandanPradhan47
 
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docxRunning head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docxcowinhelen
 
Prostate cancer Risk stratification and choice of initial treatment final.pptx
Prostate cancer Risk stratification and choice of initial treatment final.pptxProstate cancer Risk stratification and choice of initial treatment final.pptx
Prostate cancer Risk stratification and choice of initial treatment final.pptxAhmed Eliwa
 
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Le...
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Le...Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Le...
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Le...Carevive
 
Myths & Facts About Cancer.pptx
Myths & Facts About Cancer.pptxMyths & Facts About Cancer.pptx
Myths & Facts About Cancer.pptxDr Rekha Arya
 
Oncology clinical pharmacy from practice to research
Oncology clinical pharmacy from practice to researchOncology clinical pharmacy from practice to research
Oncology clinical pharmacy from practice to researchNoha El Baghdady
 

Similar to Older Adult Cancer Survivorship Challenges (20)

Cancer• What is cancer• Cancer statistics• Risk Fac.docx
Cancer• What is cancer• Cancer statistics• Risk Fac.docxCancer• What is cancer• Cancer statistics• Risk Fac.docx
Cancer• What is cancer• Cancer statistics• Risk Fac.docx
 
Survivorship and quaility of life
Survivorship and quaility of lifeSurvivorship and quaility of life
Survivorship and quaility of life
 
Screening and Preventive Care in OBGN .pdf
Screening and Preventive Care in OBGN .pdfScreening and Preventive Care in OBGN .pdf
Screening and Preventive Care in OBGN .pdf
 
2023 End of life care.pptx
2023 End of life care.pptx2023 End of life care.pptx
2023 End of life care.pptx
 
2023 End of life care.pptx
2023 End of life care.pptx2023 End of life care.pptx
2023 End of life care.pptx
 
2023 End of life care.pptx
2023 End of life care.pptx2023 End of life care.pptx
2023 End of life care.pptx
 
The Importance of Cancer Rehabilitation
The Importance of Cancer Rehabilitation The Importance of Cancer Rehabilitation
The Importance of Cancer Rehabilitation
 
Brian Sick, M.D.
Brian Sick, M.D.Brian Sick, M.D.
Brian Sick, M.D.
 
Geriatric Syndromes [Autosaved].pptx
Geriatric Syndromes [Autosaved].pptxGeriatric Syndromes [Autosaved].pptx
Geriatric Syndromes [Autosaved].pptx
 
x1.pptx
x1.pptxx1.pptx
x1.pptx
 
Lines of ttt of p ca
Lines of ttt of p caLines of ttt of p ca
Lines of ttt of p ca
 
NPEK_Cancer Presentation.pptx
NPEK_Cancer Presentation.pptxNPEK_Cancer Presentation.pptx
NPEK_Cancer Presentation.pptx
 
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docxRunning head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
 
Cancer Rehab: A Reality in Canada?
Cancer Rehab: A Reality in Canada?Cancer Rehab: A Reality in Canada?
Cancer Rehab: A Reality in Canada?
 
Prostate cancer Risk stratification and choice of initial treatment final.pptx
Prostate cancer Risk stratification and choice of initial treatment final.pptxProstate cancer Risk stratification and choice of initial treatment final.pptx
Prostate cancer Risk stratification and choice of initial treatment final.pptx
 
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Le...
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Le...Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Le...
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Le...
 
Myths & Facts About Cancer.pptx
Myths & Facts About Cancer.pptxMyths & Facts About Cancer.pptx
Myths & Facts About Cancer.pptx
 
Oncology clinical pharmacy from practice to research
Oncology clinical pharmacy from practice to researchOncology clinical pharmacy from practice to research
Oncology clinical pharmacy from practice to research
 
Late Effects of Childhood Cancer Treatments.
Late Effects of Childhood Cancer Treatments.Late Effects of Childhood Cancer Treatments.
Late Effects of Childhood Cancer Treatments.
 
Healthy people 2020 (1)
Healthy people 2020 (1)Healthy people 2020 (1)
Healthy people 2020 (1)
 

More from OSUCCC - James

In Vitro ADMET Considerations for Drug Discovery and Lead Generation
In Vitro ADMET Considerations for Drug Discovery and Lead GenerationIn Vitro ADMET Considerations for Drug Discovery and Lead Generation
In Vitro ADMET Considerations for Drug Discovery and Lead GenerationOSUCCC - James
 
Cell-Based Ion Channel and Cardiac Safety Assays
Cell-Based Ion Channel and Cardiac Safety AssaysCell-Based Ion Channel and Cardiac Safety Assays
Cell-Based Ion Channel and Cardiac Safety AssaysOSUCCC - James
 
In-Vivo Safety - Pre Ind Drug Development
In-Vivo Safety - Pre Ind Drug DevelopmentIn-Vivo Safety - Pre Ind Drug Development
In-Vivo Safety - Pre Ind Drug DevelopmentOSUCCC - James
 
The Path from Chemical Tool to Approvable Drug
The Path from Chemical Tool to Approvable DrugThe Path from Chemical Tool to Approvable Drug
The Path from Chemical Tool to Approvable DrugOSUCCC - James
 
Target Validation / Biochemical and Cellular Assay Development
Target Validation / Biochemical and Cellular Assay Development Target Validation / Biochemical and Cellular Assay Development
Target Validation / Biochemical and Cellular Assay Development OSUCCC - James
 
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...OSUCCC - James
 
Melanoma ASCO Review Update 2016
Melanoma ASCO Review Update 2016Melanoma ASCO Review Update 2016
Melanoma ASCO Review Update 2016OSUCCC - James
 
ASCO Review 2016 Upper GI Cancers
ASCO Review 2016 Upper GI CancersASCO Review 2016 Upper GI Cancers
ASCO Review 2016 Upper GI CancersOSUCCC - James
 
ASCO Review 2016 Colorectal Cancer
ASCO Review 2016 Colorectal CancerASCO Review 2016 Colorectal Cancer
ASCO Review 2016 Colorectal CancerOSUCCC - James
 
ASCO 2016 Breast Cancer Review
ASCO 2016 Breast Cancer ReviewASCO 2016 Breast Cancer Review
ASCO 2016 Breast Cancer ReviewOSUCCC - James
 
ASCO Review 2016 Addressing Health Disparities
ASCO Review 2016 Addressing Health DisparitiesASCO Review 2016 Addressing Health Disparities
ASCO Review 2016 Addressing Health DisparitiesOSUCCC - James
 
Rehabilitation Issues in Breast Cancer Survivorship
Rehabilitation Issues in Breast Cancer SurvivorshipRehabilitation Issues in Breast Cancer Survivorship
Rehabilitation Issues in Breast Cancer SurvivorshipOSUCCC - James
 
Measuring for Lower Extremity Compression Garments
Measuring for Lower Extremity Compression GarmentsMeasuring for Lower Extremity Compression Garments
Measuring for Lower Extremity Compression GarmentsOSUCCC - James
 

More from OSUCCC - James (16)

In Vitro ADMET Considerations for Drug Discovery and Lead Generation
In Vitro ADMET Considerations for Drug Discovery and Lead GenerationIn Vitro ADMET Considerations for Drug Discovery and Lead Generation
In Vitro ADMET Considerations for Drug Discovery and Lead Generation
 
Cell-Based Ion Channel and Cardiac Safety Assays
Cell-Based Ion Channel and Cardiac Safety AssaysCell-Based Ion Channel and Cardiac Safety Assays
Cell-Based Ion Channel and Cardiac Safety Assays
 
In-Vivo Safety - Pre Ind Drug Development
In-Vivo Safety - Pre Ind Drug DevelopmentIn-Vivo Safety - Pre Ind Drug Development
In-Vivo Safety - Pre Ind Drug Development
 
The Path from Chemical Tool to Approvable Drug
The Path from Chemical Tool to Approvable DrugThe Path from Chemical Tool to Approvable Drug
The Path from Chemical Tool to Approvable Drug
 
Target Validation / Biochemical and Cellular Assay Development
Target Validation / Biochemical and Cellular Assay Development Target Validation / Biochemical and Cellular Assay Development
Target Validation / Biochemical and Cellular Assay Development
 
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
 
Melanoma ASCO Review Update 2016
Melanoma ASCO Review Update 2016Melanoma ASCO Review Update 2016
Melanoma ASCO Review Update 2016
 
ASCO Review 2016 Upper GI Cancers
ASCO Review 2016 Upper GI CancersASCO Review 2016 Upper GI Cancers
ASCO Review 2016 Upper GI Cancers
 
ASCO Review 2016 Colorectal Cancer
ASCO Review 2016 Colorectal CancerASCO Review 2016 Colorectal Cancer
ASCO Review 2016 Colorectal Cancer
 
ASCO 2016 Breast Cancer Review
ASCO 2016 Breast Cancer ReviewASCO 2016 Breast Cancer Review
ASCO 2016 Breast Cancer Review
 
ASCO Review 2016 Addressing Health Disparities
ASCO Review 2016 Addressing Health DisparitiesASCO Review 2016 Addressing Health Disparities
ASCO Review 2016 Addressing Health Disparities
 
Triage Cancer
Triage CancerTriage Cancer
Triage Cancer
 
Rehabilitation Issues in Breast Cancer Survivorship
Rehabilitation Issues in Breast Cancer SurvivorshipRehabilitation Issues in Breast Cancer Survivorship
Rehabilitation Issues in Breast Cancer Survivorship
 
OT Case Study
OT Case StudyOT Case Study
OT Case Study
 
Measuring for Lower Extremity Compression Garments
Measuring for Lower Extremity Compression GarmentsMeasuring for Lower Extremity Compression Garments
Measuring for Lower Extremity Compression Garments
 
SLP Case Study
SLP Case StudySLP Case Study
SLP Case Study
 

Recently uploaded

Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar Suman
Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar SumanCall Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar Suman
Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar SumanCall Girls Service Chandigarh Ayushi
 
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...High Profile Call Girls Chandigarh Aarushi
 
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...
Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...Gfnyt
 
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real MeetChandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meetpriyashah722354
 
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130  Available With RoomVIP Kolkata Call Girl New Town 👉 8250192130  Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Roomdivyansh0kumar0
 
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real MeetCall Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meetpriyashah722354
 
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...Sheetaleventcompany
 
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service MohaliCall Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service MohaliHigh Profile Call Girls Chandigarh Aarushi
 
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.ktanvi103
 
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋Sheetaleventcompany
 
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...Call Girls Noida
 
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...Call Girls Noida
 
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR Call G...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR   Call G...❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR   Call G...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR Call G...Gfnyt.com
 
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...Vip call girls In Chandigarh
 
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in LucknowRussian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknowgragteena
 

Recently uploaded (20)

Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar Suman
Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar SumanCall Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar Suman
Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar Suman
 
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
 
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service LucknowVIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
 
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...
Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...
 
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real MeetChandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
 
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130  Available With RoomVIP Kolkata Call Girl New Town 👉 8250192130  Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Room
 
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real MeetCall Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
 
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
 
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service DehradunCall Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
 
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service MohaliCall Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
 
Call Girls in Lucknow Esha 🔝 8923113531 🔝 🎶 Independent Escort Service Lucknow
Call Girls in Lucknow Esha 🔝 8923113531  🔝 🎶 Independent Escort Service LucknowCall Girls in Lucknow Esha 🔝 8923113531  🔝 🎶 Independent Escort Service Lucknow
Call Girls in Lucknow Esha 🔝 8923113531 🔝 🎶 Independent Escort Service Lucknow
 
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
 
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.
 
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
 
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
 
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
 
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR Call G...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR   Call G...❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR   Call G...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR Call G...
 
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
 
Russian Call Girls in Dehradun Komal 🔝 7001305949 🔝 📍 Independent Escort Serv...
Russian Call Girls in Dehradun Komal 🔝 7001305949 🔝 📍 Independent Escort Serv...Russian Call Girls in Dehradun Komal 🔝 7001305949 🔝 📍 Independent Escort Serv...
Russian Call Girls in Dehradun Komal 🔝 7001305949 🔝 📍 Independent Escort Serv...
 
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in LucknowRussian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
 

Older Adult Cancer Survivorship Challenges

  • 1. Older Adult Survivorship Meghan Routt, MSN ANP/GNP-BC, AOCNP
  • 2. • I have no financial conflict of interest
  • 3. Objectives • At the end of this session the participant will be able to: • Describe some of the main barriers to treatment in the older adult population • Identify common side effects of cancer treatment and specific challenges of treatment in the older adult • Identify four common geriatric syndromes
  • 4. The “Silver Tsunami” • By the year 2050, the number of adults over the age of 65 will double (to approximately 89 million people) and will contribute a 45% increase in the number of people developing cancer 1 • Adults over the age of 65 account for 54% of all cancer patients and 69.5% of all cancer deaths occur in this age group2 • Aging is the biggest risk factor for developing cancer
  • 5. Why do we care? • Older adults have certain changes in their physiology which providers need to keep in mind when prescribing medications or other therapy Body system Changes in the older adult Skin Loses elasticity, loses ability to keep moisture in, thins, more apt for injury Renal function Decreases with age, lose 1ml/min/year of GFR after the age of 30. Renal blood flow decreases by 50% Urinary Incontinence is NEVER normal, increased frequency of urinary tract infections due to impaired bladder emptying Gastrointestinal Constipation: due to medication, due to inactivity, due to decreased peristalsis Diarrhea: more prone to dehydration, increased risk for falls
  • 6. Why do we care? Body system Changes in the older adult Liver Decreased ability to absorb and metabolize medications, medication interaction Cardiovascular Average systolic BP increases, Stroke volume does not change in older adult, increased incidence of peripheral vascular disease Pulmonary Decreased elasticity of lungs, increase in airway reactivity, decreased cough reflex Immune system Immunity decreases with age, T cell function decreases, B cells do not bind as tightly to antibodies, increase in auto-antibodies It is important to note older adults do not present with the same signs and symptoms as their younger counterparts, in fact they may present atypically with even severe illness3
  • 7. Guidelines to treat older adults with cancer
  • 8. NCCN Clinical Practice Guidelines • It is important to note, treatment is based on the patient’s goals and age is not considered a primary risk factor for surgical or medical treatment3 • Unfortunately, studies have shown older adults do not receive “standard of care” treatment for many diseases including breast cancer, colon cancer, kidney, bladder • Comprehensive Geriatric Assessments (CGA) should be done prior to any treatment • Includes assessments in all domains of health • Nutrition, Activities of daily living, Depression, Dementia, Health related quality of life, Physical exertion
  • 9. NCCN Clinical Practice Guidelines • Mucositis • Early hospitalization is needed for patients who develop dysphagia/diarrhea • Provide nutritional support • Bone marrow suppression • Prophylactic colony-stimulating factors are needed when dose intensity is required for response • Neurotoxicity • Monitor hearing loss, peripheral neuropathy and cognitive dysfunction • Cardiac toxicity • Monitor for symptomatic or asymptomatic heart failure, especially with the use of anthracyclines and trastuzumab • Renal toxicity • Adjust dose for glomerular filtration rate to reduce systemic toxicity • Insomnia • Nonpharmacologic methods are recommended • Do not use hypnotics, Benadryl or benzodiazepenes as first line treatment for insomnia
  • 10. Surgery and the older adult
  • 11. Chemotherapy and the Older Adult • Two specific tools for the older adult in monitoring chemotherapy risk assessment and toxicity: • Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) Score: http://eforms.moffitt.org/crashScore.aspx • Cancer and Aging Research Group (CARG) Chemo toxicity Calculator http://www.mycarg.org
  • 13. Tom’s story • Diagnosed with metastatic prostate cancer to bone (right hip and sacrum) • Previously underwent a total prostatectomy • Now receiving Lupron q6 months and Xjeva monthly • Tom’s major issues: • Transportation/Family Dynamics • Pain
  • 14. Tom’s Survivorship issues • Transportation and family dynamics • His ex-wife Dottie was his primary means of transportation as well as picked up him controlled substances as he no longer drives • Dottie is not his healthcare power of attorney • Dottie has had issues with alcoholism • Dottie recently diagnosed with a brain tumor • Pain • Treating urologist did not assess Tom’s pain • His primary care provider has him on MS Contin 30mg BID with norco for breakthrough
  • 15. Older adult pain management • Pain is one of the most frequently reported symptom in this age group regardless of survivorship stage5 • Furthermore, at least 42% of older adult patients with cancer report unrelieved pain6 • This is due to many factors but primarily: • Older adults’ believe that pain is a normal part of aging • They do not want to become “addicted” • Clinicians do not adequately assess their pain (occurs a lot in patients who have cognitive impairment)
  • 16. Older Adult Cancer Pain Management • Unrelieved pain can lead to depression, sleep, appetite disturbances and an increase in healthcare utilization and cost7 • Pain is often nociceptive and neuropathic pain • Older adults may achieve pain relief at lower doses than younger people who report the same severity8 • Acetaminophen or other non-steroidal anti-inflammatories is first line treatment for nociceptive pain • Narcotics often provide good pain relief and methadone is a good long acting agent in older adults due to minimal renal clearance.
  • 17. Older adult cancer pain management Retrieved from: http://www.who.int/cancer/palliative/painladder/en/
  • 18. Other Geriatric Survivorship Issues • Polypharmacy • Defined as the use of 9 or more medications • It is estimated that all people age 65 and above take two to nine prescriptions each day • Additionally, 50% take two to four over the counter medications daily and 47-59% ingest vitamins or minerals daily9 • Biggest issue occurs when a medication is prescribed to counteract a side effect of another medication • Significant risk factor in the exacerbation of common geriatric syndromes such as dementia, delirium, depression, malnutrition, falls or urinary incontinence9
  • 19. Wait…what are geriatric syndromes? • The term geriatric syndromes incorporate unique features of common health conditions in older adults • Include: Dementia, Failure to thrive, delirium, Falls, urinary incontinence • People can have one, some, or none of these]
  • 20. Risk for Falls • Thirty percent of older adults who live at home experience at least one fall annually11 • Injurious falls are also the primary cause of accidental deaths in this age group11 • It is imperative older adult cancer survivors be asked about whether they have fallen or not as well as be screened at every appointment1
  • 22. References • 1. US Department of Commerce Census Bureau (2012). Population projections. Retrieved February 15, 2016 from http://www.census.gov/population/projections/data/national/2012/summarytables.html. • 2. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF…& Cronin KA (eds). (2013). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD retrieved February 15, 2016 from: http://seer.cancer.gov/csr/1975_2011/ . • 3. Walker, M., Spivak, M., & Sebastian, M. (2014). The impact of aging physiology in critical care. Critical Care Nursing Clinics of North America, 26, 7-14. • 4. National Comprehensive Cancer Network. (2016). NCCN guidelines: Older Adult Oncology. Version 1. 2016. Retrieved from: https://www.nccn.org/professionals/physician_gls/pdf/senior.pdf • 5. Mohanty, S., Rosethal, B.A., Russell, M.M., Neuman, M.D, Ko, B.Y & Esanola, N.F. (2012) Optimal perioperative management of the geriatric patient: Best practices guideline from ACS NSQIP/American Geriatrics Society. Retrieved from: https://www.facs.org/~/media/files/quality%20programs/geriatric/acs%20nsqip%20geriatric%202016%20guidelines.ashx • 6. Beck, S., Towsley, G., Caserta, M., Lindau, K. & Dudley, W. (2009). Symptom experiences and quality of life of rural and urban older adult cancer survivors. Cancer Nursing, 32, 359-369. • 7. Barford, K. & D’Olimpio, J.T. (2008). Symptom management in geriatric oncology: Practical treatment considerations and current challenges. Current Treatment Options in Oncology, 9, 204-214. • 8. Sutton, L.M., Denmark-Wahnefried, W., & Clipp, E.C. (2003). Management of terminal cancer in elderly patients, Lancet Oncology, 4, 149-157. • 9. Mercadante, S. & Arcuri, E. (2007). Pharmacological management of cancer pain in the elderly. Drugs and Aging, 24, 761-776 • 10. Flood, K.L., Carrol, M.B., Le, C.V. & Brown, C.J. (2009). Polypharmacy in hospitalized older adult cancer patients: Experience from a prospective, observational study of an oncology-acute care for elders unit. American Journal of Geriatric Pharmacotherapy, 7, 151-158. • 11. Day., L., Fildes, B., Gordon, I., Fitzharris, M., Flamer, H., & Lord, S. (2002). Randomised factorial trial of falls prevention among older people living in their own homes. BMJ, 325, 128.